Aroa Biosurgery in trading halt for capital raise

Aroa Biosurgery in trading halt for capital raise
Aroa has five products approved for sale in the US. (Image: Supplied)
Rebecca Stevenson
New Zealand headquartered medical company Aroa will raise capital to boost its presence in the US.The Australian Financial Review reported the company was seeking A$52 million to fund the expansion of its US sales team, as well as research and development.In a June market update, the soft-tissue regeneration company said US medical procedure numbers continued to reflect a positive trend “supporting improved sales momentum”.Aroa has commercial operations based in San Diego and sales professionals across the US. In its 2021 results fo...

More Markets

NZ sharemarket celebrates highest single-day rise in over five months
Markets Market close

NZ sharemarket celebrates highest single-day rise in over five months

The S&P/NZX 50 Index closed at 11,946.43, increasing 143.15 points or 1.21%.

Graham Skellern 24 Apr 2024
'Serious compliance breaches' in NZ sharemarket
Markets

'Serious compliance breaches' in NZ sharemarket

Seven matters were referred to the NZ Markets Disciplinary Tribunal last year.

Murray Jones 24 Apr 2024
Which NZX firms lost or gained NZ Super Fund investment
Markets

Which NZX firms lost or gained NZ Super Fund investment

The fund is an active investor in NZ. Here are the firms it likes, and those it dumped.

Gas fears weigh on Genesis, push up power prices
Markets

Gas fears weigh on Genesis, push up power prices

Worries about gas supply hit more than share prices.

Ian Llewellyn 24 Apr 2024